Stay updated on ESMART: Molecular Stratification Clinical Trial

Sign up to get notified when there's something new on the ESMART: Molecular Stratification Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ESMART: Molecular Stratification Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added a new publication citation to Publications: Rubio-San-Simon A et al., Phase I/II Study of the CDK2/9 Inhibitor Fadraciclib in Children with Advanced Malignancies (Arm K of the AcSe-ESMART Trial), Target Oncol. 2026 Mar 16, DOI: 10.1007/s11523-026-01208-1. Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T19:28:56.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T16:43:47.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the funding-status notice and the prior revision note (v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T02:45:00.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    I implemented a new site notice about the lapse in government funding and the NIH Clinical Center status, including guidance to visit cc.nih.gov and opm.gov. The page also shows Revision: v3.4.1, replacing the prior v3.4.0 tag.
    Difference
    0.2%
    Check dated 2026-02-03T23:57:57.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Additions: Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-28T00:15:52.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Added a new experimental Arm R Capivasertib + metronomic Vinorelbine with dosing details and drug synonyms AZD5363 and TRUQAP, expanding the study's treatment options. Updated contacts: Estelle Jullemier is now listed; Jonathan Rubino's contact was removed.
    Difference
    1%
    Check dated 2026-01-20T23:56:40.000Z thumbnail image

Stay in the know with updates to ESMART: Molecular Stratification Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ESMART: Molecular Stratification Clinical Trial page.